Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             53 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Achievement of low-density lipoprotein cholesterol thresholds in very high-risk atherosclerotic cardiovascular disease Worledge, Elisa A.

19 4 p. 860-868
artikel
2 Age and effect of intensive statin in acute mild ischemic stroke or transient ischemic attack: Subgroup analysis of the INSPIRES trial Jiang, Lingling

19 4 p. 802-811
artikel
3 ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk Sehayek, Daniel

19 4 p. 844-859
artikel
4 A qualitative study to explore the patient experience of hypertriglyceridemia-related acute pancreatitis Kessler, Asia Sikora

19 4 p. 931-941
artikel
5 Association between uric acid to high-density lipoprotein cholesterol ratio and abdominal aortic calcification: A cross-sectional study Li, Yuanming

19 4 p. 899-911
artikel
6 Beyond the cataract: Comprehensive ophthalmologic and retinal imaging analysis in cerebrotendinous xanthomatosis Tiryaki Demir, Semra

19 4 p. 990-999
artikel
7 Cardiovascular disease and cholesterol lowering therapy in women and men with molecularly defined heterozygous familial hypercholesterolemia from Brazil Maia, Kleisson P.

19 4 p. 1044-1054
artikel
8 Cardiovascular risk and lipid control in older adults: Compliance with LDL and non-HDL cholesterol and triglyceride goals in a national cross-sectional study Bueno, Cristian Orlando Porras

19 4 p. 869-877
artikel
9 Characterization of familial chylomicronemia syndrome in a compound heterozygote for 2 APOA5 nonsense variants Mueller, Paul A.

19 4 p. 1091-1100
artikel
10 Cholesteryl ester transfer protein activity correlates inversely with apolipoprotein A5 levels Wen, Yi

19 4 p. 1073-1084
artikel
11 Circulating apolipoprotein B levels in statin-treated type 2 diabetic patients with coronary artery disease: Implications for coronary atheroma progression and instability Funabashi, Sayaka

19 4 p. 888-898
artikel
12 Clinical case series: Spontaneous coronary artery dissection with thrombosis among young individuals with high lipoprotein(a) Koczo, Agnes

19 4 p. 1148-1152
artikel
13 Clinical variability in cerebrotendinous xanthomatosis (CTX): Insights from 16 cases across Gulf Cooperation Council’s (GCC’s) high consanguineous population Almuqbil, Mohammed A.

19 4 p. 1000-1008
artikel
14 Contributing factors to the short-term progression of carotid plaque and its relation to cardiovascular outcomes Park, Jong-Il

19 4 p. 878-887
artikel
15 Corrigendum to Lipoprotein particle profile in the presence of peripheral artery disease among patients with coronary heart disease: Data from the CORDIOPREV study, Journal of Clinical Lipidology 19 (2025) 256–266 de la Cruz-Ares, Silvia

19 4 p. 1184
artikel
16 Discontinuation of lipid-modifying agents and failure to achieve target LDL cholesterol levels across cardiovascular risk groups Orman, Zhomart

19 4 p. 835-843
artikel
17 Effect of olezarsen on routinely measured lipase and amylase levels in familial chylomicronemia syndrome Alexander, Veronica J.

19 4 p. 1109-1118
artikel
18 Effects of dietary cholesterol and eggs on circulating low-density lipoprotein cholesterol: Old news from a new study Duell, P. Barton

19 4 p. 719-722
artikel
19 Erratum to “Scientific Poster Abstracts Selected for the National Lipid Association 2025 Scientific Sessions, May 29 – June 1, 2025, Miami, Florida” [Journal of Clinical Lipidology, Volume 19 (2025), Issue 3, Supplemental, May-June, 2025, e1-e128]
19 4 p. 1185-1196
artikel
20 Estimate and prognosis of patients who are candidates for treatment with eicosapentaenoic acid after an acute coronary syndrome Cordero, Alberto

19 4 p. 827-834
artikel
21 Evaluation of lipid-lowering therapy in patients with elevated lipoprotein(a) levels Kelly, Michael S.

19 4 p. 819-826
artikel
22 Familial hypercholesterolemia in Sri Lanka: Addressing evidence gaps and paving the road ahead Matthias, Anne Thushara

19 4 p. 1145-1147
artikel
23 Global disparities in access to lipid-lowering therapies for patients with homozygous familial hypercholesterolemia – A physician survey Schonck, Willemijn A.M.

19 4 p. 1009-1019
artikel
24 Global trends in sitosterolemia research: A bibliometric and visualization analysis Wu, Hui

19 4 p. 790-801
artikel
25 Heterozygous pathogenic PPARG variants in patients with severe hypertriglyceridemia Hang, Shyann

19 4 p. 1085-1090
artikel
26 Homozygous familial hypercholesterolemia in a high-consanguinity population: Insights from a Saudi cohort Alsagheir, Afaf

19 4 p. 1055-1063
artikel
27 Hypertriglyceridemia and its relationship with all-cause mortality and pancreatitis: Results from a large retrospective clinical registry Vlacho, Bogdan

19 4 p. 922-930
artikel
28 Implementation of a machine learning model and direct-to-patient outreach program for targeted screening for familial hypercholesterolemia Hennessey, Kerrilynn C.

19 4 p. 1029-1036
artikel
29 Improvement of retinal microvascular function after initiation of lipid-lowering therapy with PCSK9 inhibitors - An observational study Nägele, Matthias P.

19 4 p. 982-989
artikel
30 Increased prevalence of coronary heart disease among current smokers carrying APOL1 risk variants within the African American population Mustra Rakic, Jelena

19 4 p. 1129-1138
artikel
31 Insights from a real-world experience with inclisiran at a large United States lipid clinic Mazdeyasnan, Donya

19 4 p. 812-818
artikel
32 Integrating genetics and lifestyles for precision nutrition in hypertriglyceridemia: A UK Biobank and KoGES analysis Hur, Haeng Jeon

19 4 p. 942-959
artikel
33 Is Tangier disease a rare cause of premature ovarian insufficiency?: A case report Babayeva, Afruz

19 4 p. 1158-1163
artikel
34 JCL Roundtable: Dietary recommendations and intermittent fasting and time-restricted eating Maki, Kevin C.

19 4 p. 748-758
artikel
35 Lipoprotein X – Pathophysiology, diagnosis, and management Kalra, Dinesh K.

19 4 p. 759-774
artikel
36 Lomitapide-induced fatty liver is a reversible condition: Evidence from a case of familial chylomicronemia syndrome Tramontano, Daniele

19 4 p. 1164-1170
artikel
37 Long-term experience with lomitapide treatment in patients with homozygous familial hypercholesterolemia: Over 10 years of efficacy and safety data Arca, Marcello

19 4 p. 775-789
artikel
38 LpX and LpZ associated hypercholesterolemia in a patient with primary sclerosing cholangitis – A case report Gurevitz, Chen

19 4 p. 1171-1173
artikel
39 Multidisciplinary teams in clinical lipidology and cardiometabolic care: A National Lipid Association Expert Clinical Review Cheeley, Mary Katherine

19 4 p. 737-747
artikel
40 Multiple coronary artery aneurysms in a young patient with Kawasaki disease and heterozygous familial hypercholesterolemia: A case study West, Julianna

19 4 p. 1174-1178
artikel
41 Neurodegeneration in familial chylomicronemia syndrome Bashir, Bilal

19 4 p. 1119-1128
artikel
42 Patients’ and families’ virtual care experiences for hypercholesterolemia management during the COVID-19 pandemic Chahal, Nita

19 4 p. 969-981
artikel
43 Performance of the FIND-FH machine learning algorithm for the identification of individuals with suspected familial hypercholesterolemia Carter, Spencer V.

19 4 p. 1037-1043
artikel
44 Prevention of acute systemic reaction during LDL apheresis post COVID-19 by icatibant pretreatment Davidson, Lauren R.

19 4 p. 1153-1157
artikel
45 Real life evidence of volanesorsen for familial chylomicronemia syndrome in Colombia Román-González, Alejandro

19 4 p. 1101-1108
artikel
46 Recognition and management of persistent chylomicronemia: A Joint Expert Clinical Consensus by the National Lipid Association and the American Society for Preventive Cardiology Saadatagah, Seyedmohammad

19 4 p. 723-736
artikel
47 Shorter prepubertal children have higher cholesterol levels Kafol, Jan

19 4 p. 1181-1183
artikel
48 Sitosterolemia caused by compound heterozygosis of 2 allelic variants in the ABCG5 gene—21 years of follow-up Coutinho, Jean G.V.

19 4 p. 1139-1144
artikel
49 The analysis of the breakpoint of large rearrangements of LDLR gene in a Taiwanese cohort of patients with familial hypercholesterolemia Huang, Chin-Chou

19 4 p. 1064-1072
artikel
50 The unsolved question of the most optimal combination of lipid-lowering therapies Cordero, Alberto

19 4 p. 1179-1180
artikel
51 Triglyceride-glucose index and 28-day all-cause mortality in critically ill obese patients: A MIMIC-IV database analysis Wang, Wen-qiang

19 4 p. 960-968
artikel
52 Using healthcare claims data to identify health disparities for individuals with familial hypercholesterolemia McGowan, Mary P.

19 4 p. 1020-1028
artikel
53 When ‘good’ cholesterol goes awry: Cross-sectional association of high HDL-C with prevalent sarcopenia in U.S. adults Xie, Rong-Zhen

19 4 p. 912-921
artikel
                             53 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland